Andrew S Flum1, Laurie Bachrach1, Borko D Jovanovic2, Irene B Helenowski2, Sarah C Flury1, Joshua J Meeks3. 1. Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL. 2. Division of Biostatistics, Department of Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL. 3. Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL. Electronic address: joshua.meeks@northwestern.edu.
Abstract
OBJECTIVE: To characterize the current patterns of retroperitoneal lymph node dissection (RPLND) performance among practicing US urologists. METHODS: Six-month case log data of urologists certifying between 2003 and 2013 were obtained from the American Board of Urology. Cases specifying both an International Classification of Diseases, Ninth Revision code for testis cancer and a Current Procedural Terminology code for RPLND were analyzed for surgeon-specific variables. RESULTS: Among 8545 certifying urologists, 290 (3.4% of all) urologists logged 553 RPLNDs in the case log system with 21 (3.6%) performed laparoscopically. Median number of RPLNDs logged annually was 1 (range, 1-59; interquartile range, 1-1) with 3 urologists performing 23% of all RPLNDs. Seventy-five percent of urologists logged a single RPLND. Urologists who logged 2 RPLNDs in a year were in the top 25% of performers with over half (52%) of all RPLNDs performed by urologists who logged 1 or 2 RPLND. On univariate regression analysis, oncology specialization (odds ratio, 5.1 [95% confidence interval, 2.2-11.6; P = .0001]) and non-private practice type (odds ratio, 2.8 [95% confidence interval, 1.1-7.1; P = .03]) were predictive of top 10% (≥ 3 cases) surgeon RPLND volume. CONCLUSION: Despite the critical importance of the surgical quality for outcomes of patients with testis cancer, the majority of surgeons performing RPLND are certifying for the first time and log only 1 RPLND.
OBJECTIVE: To characterize the current patterns of retroperitoneal lymph node dissection (RPLND) performance among practicing US urologists. METHODS: Six-month case log data of urologists certifying between 2003 and 2013 were obtained from the American Board of Urology. Cases specifying both an International Classification of Diseases, Ninth Revision code for testis cancer and a Current Procedural Terminology code for RPLND were analyzed for surgeon-specific variables. RESULTS: Among 8545 certifying urologists, 290 (3.4% of all) urologists logged 553 RPLNDs in the case log system with 21 (3.6%) performed laparoscopically. Median number of RPLNDs logged annually was 1 (range, 1-59; interquartile range, 1-1) with 3 urologists performing 23% of all RPLNDs. Seventy-five percent of urologists logged a single RPLND. Urologists who logged 2 RPLNDs in a year were in the top 25% of performers with over half (52%) of all RPLNDs performed by urologists who logged 1 or 2 RPLND. On univariate regression analysis, oncology specialization (odds ratio, 5.1 [95% confidence interval, 2.2-11.6; P = .0001]) and non-private practice type (odds ratio, 2.8 [95% confidence interval, 1.1-7.1; P = .03]) were predictive of top 10% (≥ 3 cases) surgeon RPLND volume. CONCLUSION: Despite the critical importance of the surgical quality for outcomes of patients with testis cancer, the majority of surgeons performing RPLND are certifying for the first time and log only 1 RPLND.
Authors: Torgrim Tandstad; Christian K Kollmannsberger; Bruce J Roth; Claudio Jeldres; Silke Gillessen; Karim Fizazi; Siamak Daneshmand; William T Lowrance; Nasser H Hanna; Costantine Albany; Richard Foster; Gabriella Cohn Cedermark; Darren R Feldman; Thomas Powles; Mark A Lewis; Peter Scott Grimison; Douglas Bank; Christopher Porter; Peter Albers; Maria De Santis; Sandy Srinivas; George J Bosl; Craig R Nichols Journal: J Clin Oncol Date: 2017-08-30 Impact factor: 44.544
Authors: Liam C Macleod; Saneal Rajanahally; Jasmir G Nayak; Brodie A Parent; Jorge D Ramos; George R Schade; Sarah K Holt; Atreya Dash; John L Gore; Daniel W Lin Journal: Urology Date: 2016-01-21 Impact factor: 2.649
Authors: Hiten D Patel; Gregory A Joice; Zeyad R Schwen; Alice Semerjian; Ridwan Alam; Arnav Srivastava; Mohamad E Allaf; Phillip M Pierorazio Journal: World J Urol Date: 2017-10-12 Impact factor: 4.226
Authors: Joost M Blok; Richard P Meijer; Henk G van der Poel; Axel Bex; Jeanette van Vooren; Japke J van Urk; Simon Horenblas; J L H Ruud Bosch Journal: World J Urol Date: 2020-05-05 Impact factor: 4.226